azelastine has been researched along with Dermatitis, Atopic in 2 studies
azelastine: azeptin is azelastine hydrochloride; structure; eye drop formulation effective in relieving symptoms of allergic conjunctivitis; do not confuse with 5-loxin which is an extract of Boswellia
azelastine : A phthalazine compound having an oxo substituent at the 1-position, a 1-methylazepan-4-yl group at the 2-position and a 4-chlorobenzyl substituent at the 4-position.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with azelastine (4 mg/os once daily) inhibited immediate reactions to allergens by 65% (range 55-74) and to histamine by 68% (range 47-82)." | 2.69 | Investigation of the anti-allergic activity of azelastine on the immediate and late-phase reactions to allergens and histamine using telethermography. ( Bähre, M; De Weck, AL; Derer, T, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamamoto, Y | 1 |
| Nagai, K | 1 |
| Muto, M | 1 |
| Asagami, C | 1 |
| De Weck, AL | 1 |
| Derer, T | 1 |
| Bähre, M | 1 |
1 trial available for azelastine and Dermatitis, Atopic
| Article | Year |
|---|---|
Investigation of the anti-allergic activity of azelastine on the immediate and late-phase reactions to allergens and histamine using telethermography.
Topics: Adult; Allergens; Alternaria; Anti-Allergic Agents; Asthma; Cross-Over Studies; Dermatitis, Atopic; | 2000 |
1 other study available for azelastine and Dermatitis, Atopic
| Article | Year |
|---|---|
Inhibitory effect of azelastine, a potent antiallergic agent, on release of tumor necrosis factor-alpha from activated human peripheral blood mononuclear cells and U937 cells.
Topics: Depression, Chemical; Dermatitis, Atopic; Humans; Monocytes; Neoplasm Proteins; Phthalazines; Phytoh | 1993 |